Provided by Tiger Trade Technology Pte. Ltd.

Bio-Rad Laboratories

367.92
-0.9100-0.25%
Post-market: 367.12-0.8000-0.22%19:30 EDT
Volume:251.90K
Turnover:93.22M
Market Cap:9.85B
PE:44.55
High:374.60
Open:373.16
Low:363.98
Close:368.83
52wk High:396.23
52wk Low:236.73
Shares:26.76M
Float Shares:22.32M
Volume Ratio:1.09
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.26
EPS(LYR):27.85
ROE:3.11%
ROA:1.66%
PB:1.37
PE(LYR):13.21

Loading ...

Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention

GlobeNewswire
·
Jul 02

BIO-key Showcases Passwordless & Biometric Identity Solutions at Jordan Banking Cybersecurity Workshop in Amman on July 6th

GlobeNewswire
·
Jul 02

Bell Potter Keeps Their Buy Rating on Biome Australia Ltd (BIO)

TIPRANKS
·
Jul 02

Movement Alert|Bio-Rad Laboratories Falls 14.18% in Pre-Market Trading, Trading at $317.09

Market Focus
·
Jun 26

S&P 500 Futures Drop in Premarket Trading; on Semiconductor, Davita Lag

Dow Jones
·
Jun 26

CEL-SCI, Saudi Amarox hold strategic agreement signing at BIO 2026

TIPRANKS
·
Jun 24

Contract Research Organization Stocks Surge as BIO Conference Highlights Chinese CXO Global Competitiveness; Pharmaceutical Sector Openness Achieves New Milestone

Stock News
·
Jun 24

Neurizon strengthens NUZ-001 ALS case with new mechanistic data at BIO 2026

TIPRANKS
·
Jun 23

VERAXA Biotech (NASDAQ: VRXA) Showcases BiTAC Cancer Platforms Ahead of BIO International Convention

TIPRANKS
·
Jun 22

Thermo Fisher to showcase new capabilities at BIO International 2026

TIPRANKS
·
Jun 22

Genflow’s Chair to Spotlight Longevity and RNA Therapeutics at BIO 2026

TIPRANKS
·
Jun 22

Bio Protocol launches AI research hub to challenge grant gatekeepers

cryptonews
·
Jun 20

BioHarvest Sciences to Showcase Botanical Synthesis at 2026 BIO International Convention

TIPRANKS
·
Jun 19

How Stronger Results and Institutional Selling At Bio-Rad Laboratories (BIO) Has Changed Its Investment Story

Simply Wall St.
·
Jun 19

BIO-key’s Fireside Chat at Maxim Group Defense Tech Conf. to Webcast Thur. June 25 at 4pm ET

GlobeNewswire
·
Jun 18

VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026

GlobeNewswire
·
Jun 18

Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026

GlobeNewswire
·
Jun 17

Silexion Therapeutics to Attend BIO International Convention 2026

GlobeNewswire
·
Jun 17

Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026

GlobeNewswire
·
Jun 15

SL BIO Ltd. and Horizon Space Acquisition II Announce Closing of Business Combination and Listing on the Nasdaq Global Market

GlobeNewswire
·
Jun 13